Dave Johnson, Chief Strategic Officer at Chorus, discussed the company's mission to create healthier indoor spaces using technology developed to combat Ebola. Chorus, based in Massachusetts, focuses on three areas: indoor agriculture, food freshness, and human health in indoor spaces.

The company's first products, utilizing chlorine dioxide, are set to launch in Q1 2025, with a pilot program already underway. Chorus has four issued patents and is targeting the indoor cannabis market first. The team comprises experienced entrepreneurs and scientists, backed by a deep advisory board. The company will exhibit at MJ Biz in December, showcasing prototypes and offering site visits to interested cultivators.